Showing results (31-40 of 144) with videos related to
Sort By:
Pageof 15
International Journal of General Medicine|September 18, 2023
<i>KRAS/NRAS</i> Mutations Associated with Distant Metastasis and <i>BRAF/PIK3CA</i> Mutations Associated with Poor Tumor Differentiation in Colorectal CancerJuanzi Zeng, Wenwei Fan, Jiaquan Li, et al.International Journal of Molecular Medicine|November 25, 2020
CircRNAs open a new era in the study of cardiovascular disease (Review)Zhikang Yu, Qingyan Huang, Qunji Zhang, et al.Frontiers in Genetics|October 4, 2021
Analysis of Genomic Copy Number Variation in Miscarriages During Early and Middle PregnancyHeming Wu, Qingyan Huang, Xia Zhang, et al.Journal of Clinical Laboratory Analysis|April 7, 2025
Chromosomal Microarray Analysis and Karyotype Analysis for Prenatal Diagnosis of Fetuses With Abnormal Ultrasound Soft MarkersLina Liu, Lingna She, Zhiyuan Zheng, et al.Reproductive Sciences (Thousand Oaks, Calif.)|May 16, 2022
Chromosomal Copy Number Variation Analysis in Pregnancy Products from Recurrent and Sporadic Miscarriage Using Next-Generation SequencingXia Zhang, Heming Wu, Zhonghang Gu, et al.Clinical Laboratory|March 13, 2020
The Serum Tumor Markers in Combination for Clinical Diagnosis of Lung CancerHeming Wu, Qiuming Wang, Qinghua Liu, et al.Journal of Clinical Laboratory Analysis|October 6, 2021
Dihydropyrimidine dehydrogenase (DPYD) gene c.1627A>G A/G and G/G genotypes are risk factors for lymph node metastasis and distant metastasis of colorectal cancerJuanzi Zeng, Heming Wu, Qingyan Huang, et al.BMC Medical Genomics|January 3, 2024
BRCA1 and BRCA2 germline mutations in Chinese Hakka breast cancer patientsYinmei Zhang, Heming Wu, Caiyan Gan, et al.Journal of Clinical Laboratory Analysis|September 7, 2019
Circulating microRNA expression profiling and bioinformatics analysis of patients with coronary artery disease by RNA sequencingZhixiong Zhong, Wei Zhong, Qifeng Zhang, et al.International Journal of General Medicine|March 18, 2022
The Features of <i>BRCA1</i> and <i>BRCA2</i> Germline Mutations in Hakka Ovarian Cancer Patients: <i>BRCA1</i> C.536 A>T Maybe a Founder Mutation in This PopulationYu Luo, Heming Wu, Qingyan Huang, et al.Pageof 15